Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Buy
61
KRMD Quote, Financials, Valuation and Earnings
Last price:
$6.06
Seasonality move
:
19.21%
Day range:
$5.98 - $6.23
52-week range:
$1.86 - $6.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.15x
P/B ratio:
17.05x
Volume:
89.2K
Avg. volume:
200.4K
1-year change:
53.81%
Market cap:
$280.7M
Revenue:
$33.6M
EPS (TTM):
-$0.08
Analysts' Opinion
-
Consensus RatingKORU Medical Systems, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.25, KORU Medical Systems, Inc. has an estimated upside of 3.14% from its current price of $6.06.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $6.06.
Fair Value
-
According to the consensus of 5 analysts, KORU Medical Systems, Inc. has 3.14% upside to fair value with a price target of $6.25 per share.
KRMD vs. S&P 500
-
Over the past 5 trading days, KORU Medical Systems, Inc. has overperformed the S&P 500 by 4.88% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
KORU Medical Systems, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
KORU Medical Systems, Inc. has grown year-over-year revenues for 7 quarters straight. In the most recent quarter KORU Medical Systems, Inc. reported revenues of $10.4M.
Earnings Growth
-
KORU Medical Systems, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter KORU Medical Systems, Inc. reported earnings per share of -$0.02.
Enterprise value:
275.9M
EV / Invested capital:
13.70x
Price / LTM sales:
7.15x
EV / EBIT:
--
EV / Revenue:
7.06x
PEG ratio (5yr expected):
-0.28x
EV / Free cash flow:
-1,544.93x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$23.5M
Return On Assets:
-13.68%
Net Income Margin (TTM):
-9.5%
Return On Equity:
-22.13%
Return On Invested Capital:
-18.02%
Operating Margin:
-8.34%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $28.7M | $32M | $39.1M | $8.2M | $10.4M | |
| Gross Profit | $15.6M | $19.2M | $23.5M | $5M | $6.1M | |
| Operating Income | -$10.6M | -$7.1M | -$4M | -$1.7M | -$867.7K | |
| EBITDA | -$9.8M | -$6.1M | -$3.2M | -$1.5M | -$663.2K | |
| Diluted EPS | -$0.18 | -$0.26 | -$0.08 | -$0.03 | -$0.02 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $37.7M | $30.7M | $21.7M | $18.9M | $19.4M | |
| Total Assets | $41.4M | $42.7M | $35.4M | $27.4M | $27.1M | |
| Current Liabilities | $4.6M | $6.2M | $4.2M | $6.3M | $7.8M | |
| Total Liabilities | $4.6M | $10.2M | $7.9M | $9.7M | $10.6M | |
| Total Equity | $36.8M | $32.5M | $27.4M | $17.7M | $16.5M | |
| Total Debt | $804.8K | $4.1M | $3.8M | $3.4M | $2.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$4.7M | -$162.5K | $307.3K | -$923.9K | $65.5K | |
| Cash From Investing | -$830.1K | -$1.6M | -$477.4K | -$1.1M | -$52.5K | |
| Cash From Financing | -$186.1K | -$211.2K | -$172.2K | $374.5K | $396.3K | |
| Free Cash Flow | -$5.5M | -$1.8M | -$178.6K | -$2M | $13K | |
KRMD
Sector
Market Cap
$280.7M
$28.2M
Price % of 52-Week High
91.71%
50.25%
Dividend Yield
0%
0%
Shareholder Yield
-0.02%
-1.54%
1-Year Price Total Return
53.81%
-18.1%
Beta (5-Year)
0.576
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$6.05
200-day SMA
Buy
Level
$3.74
Bollinger Bands (100)
Buy
Level
3.71 - 5.27
Chaikin Money Flow
Buy
Level
2.1M
20-day SMA
Buy
Level
$5.87
Relative Strength Index (RSI14)
Buy
Level
60.66
ADX Line
Buy
Level
28
Williams %R
Neutral
Level
-46.9178
50-day SMA
Buy
Level
$4.93
MACD (12, 26)
Buy
Level
0.36
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Neutral
Level
3.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (8.6121)
Sell
CA Score
(Annual)
Level (-0.3191)
Buy
Beneish M-Score
(Annual)
Level (-2.6326)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (2.97)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.
Stock Forecast FAQ
In the current month, KRMD has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The KRMD average analyst price target in the past 3 months is $6.25.
-
Where Will KORU Medical Systems, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that KORU Medical Systems, Inc. share price will rise to $6.25 per share over the next 12 months.
-
What Do Analysts Say About KORU Medical Systems, Inc.?
Analysts are divided on their view about KORU Medical Systems, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that KORU Medical Systems, Inc. is a Sell and believe this share price will drop from its current level to $4.00.
-
What Is KORU Medical Systems, Inc.'s Price Target?
The price target for KORU Medical Systems, Inc. over the next 1-year time period is forecast to be $6.25 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is KRMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for KORU Medical Systems, Inc. is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of KRMD?
You can purchase shares of KORU Medical Systems, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase KORU Medical Systems, Inc. shares.
-
What Is The KORU Medical Systems, Inc. Share Price Today?
KORU Medical Systems, Inc. was last trading at $6.06 per share. This represents the most recent stock quote for KORU Medical Systems, Inc.. Yesterday, KORU Medical Systems, Inc. closed at $6.06 per share.
-
How To Buy KORU Medical Systems, Inc. Stock Online?
In order to purchase KORU Medical Systems, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get KRMD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KRMD
Sector
P/E ratio
--
23.92x
PEG ratio
-0.28x
-0.01x
P/B ratio
17.05x
1.83x
Price / LTM sales
7.15x
1.61x
Growth Metrics
KRMD
Sector
Revenue growth
27.17%
4.6%
Earnings growth
51.3%
10.88%
Revenue (5-year growth)
7.75%
6.46%
Earnings forecast
-$0.02
-$0.21
Profitability
KRMD
Sector
Profitability FY 2024
$20.4M
$3.5M
Return on invested capital
-18.02%
-31.84%
Return on assets
-13.68%
-27.96%
Return on equity
-22.13%
-37.63%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
11
Estimated Next Earnings Date
Feb
11
Balance Sheet
KRMD
Sector
Total cash
$8.5M
$26.3M
Short term investments
--
$25.7M
Total assets
$28.5M
$76.9M
Long term debt
$2.9M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is up 18.01% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 18.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
